Drugplain

Ohtuvayre 3 mg/2.5mL

ensifentrine · SUSPENSION · MERCK SHARP & DOHME LLC

No Recall History
Plain English

Ohtuvayre (ensifentrine) is an inhaled medication used to treat chronic obstructive pulmonary disease (COPD) that works by relaxing airway muscles and reducing inflammation. It belongs to a class of drugs called phosphodiesterase 3 inhibitors and comes as a liquid suspension that you breathe in through your lungs.

Key Facts

Brand Name
Ohtuvayre
Generic Name
ensifentrine
NDC Code (Product)
83034-003
Manufacturer
MERCK SHARP & DOHME LLC
Strength
3 mg/2.5mL
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Marketing Status
Application #
NDA217389
Drug Class
Phosphodiesterase 3 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitor [EPC]
Marketing Start
06/26/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

dyspnoea253 reports
back pain77 reports
cough74 reports
diarrhoea73 reports
drug ineffective73 reports
chronic obstructive pulmonary disease71 reports
pneumonia53 reports
chest discomfort47 reports
headache46 reports
anxiety37 reports

Frequently Asked Questions

What is Ohtuvayre used for?

Ohtuvayre (ensifentrine) is an inhaled medication used to treat chronic obstructive pulmonary disease (COPD) that works by relaxing airway muscles and reducing inflammation. It belongs to a class of drugs called phosphodiesterase 3 inhibitors and comes as a liquid suspension that you breathe in through your lungs.

Is Ohtuvayre a controlled substance?

Ohtuvayre is not classified as a controlled substance by the DEA.

What is the generic name for Ohtuvayre?

The generic name for Ohtuvayre is ensifentrine. There are no other listed brand versions of ensifentrine.

What is the NDC code for Ohtuvayre 3 mg/2.5mL?

The NDC (National Drug Code) for Ohtuvayre 3 mg/2.5mL is 83034-003, listed by MERCK SHARP & DOHME LLC.

Product NDC

83034-003

Package NDC

83034-003-60

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)